Corient Private Wealth LP Invests $245.52 Million in UnitedHealth Group Incorporated $UNH

Corient Private Wealth LP acquired a new position in UnitedHealth Group Incorporated (NYSE:UNH) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 8,451,751 shares of the healthcare conglomerate’s stock, valued at approximately $245,516,000.

Several other institutional investors have also added to or reduced their stakes in the business. Sarver Vrooman Wealth Advisors acquired a new position in shares of UnitedHealth Group during the fourth quarter valued at about $25,000. Aberdeen Wealth Management LLC purchased a new stake in UnitedHealth Group during the 2nd quarter worth approximately $31,000. Anfield Capital Management LLC raised its holdings in shares of UnitedHealth Group by 220.0% in the fourth quarter. Anfield Capital Management LLC now owns 80 shares of the healthcare conglomerate’s stock worth $26,000 after buying an additional 55 shares during the last quarter. Joseph Group Capital Management purchased a new stake in shares of UnitedHealth Group during the fourth quarter valued at $27,000. Finally, Nalls Sherbakoff Group LLC acquired a new stake in UnitedHealth Group during the 4th quarter worth about $27,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on UNH shares. Truist Financial increased their price objective on UnitedHealth Group from $440.00 to $480.00 and gave the company a “buy” rating in a report on Tuesday, July 14th. Weiss Ratings downgraded UnitedHealth Group from a “hold (c)” rating to a “hold (c-)” rating in a report on Tuesday, July 28th. Bank of America reiterated a “buy” rating on shares of UnitedHealth Group in a research note on Monday, July 20th. JPMorgan Chase & Co. raised their price target on shares of UnitedHealth Group from $466.00 to $516.00 and gave the company an “overweight” rating in a research report on Tuesday, July 21st. Finally, Robert W. Baird upgraded shares of UnitedHealth Group from an “underperform” rating to a “neutral” rating and upped their price objective for the stock from $287.00 to $453.00 in a research report on Thursday, July 16th. Two research analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $456.56.

Insiders Place Their Bets

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 1,169 shares of UnitedHealth Group stock in a transaction on Friday, August 21st. The shares were sold at an average price of $390.00, for a total transaction of $455,910.00. Following the sale, the chief executive officer owned 15,328 shares of the company’s stock, valued at $5,977,920. The trade was a 7.09% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 0.19% of the company’s stock.

UnitedHealth Group Trading Down 1.6%

Shares of NYSE:UNH opened at $394.57 on Friday. The firm has a market capitalization of $354.16 billion, a price-to-earnings ratio of 25.39, a price-to-earnings-growth ratio of 1.39 and a beta of 0.62. The business’s 50 day moving average price is $413.42 and its 200-day moving average price is $359.88. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.78 and a quick ratio of 0.78. UnitedHealth Group Incorporated has a 1 year low of $255.96 and a 1 year high of $461.62.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.94 by $1.44. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The business had revenue of $112.03 billion for the quarter, compared to the consensus estimate of $110.81 billion. During the same period last year, the firm posted $4.08 earnings per share. The company’s revenue was up .4% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 19.82 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 22nd. Stockholders of record on Monday, September 14th will be paid a $2.32 dividend. The ex-dividend date of this dividend is Monday, September 14th. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.4%. UnitedHealth Group’s payout ratio is currently 59.72%.

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.